BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17102094)

  • 1. The norepinephrine transporter and pheochromocytoma.
    Cleary S; Phillips JK
    Ann N Y Acad Sci; 2006 Aug; 1073():263-9. PubMed ID: 17102094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxytyrosol increases norepinephrine transporter function in pheochromocytoma cells.
    Luzón-Toro B; Geerlings A; Hilfiker S
    Nucl Med Biol; 2008 Oct; 35(7):801-4. PubMed ID: 18848665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of mIBG and catecholamines in noradrenaline- and organic cation transporter-expressing cells: potential use of corticosterone for a preferred uptake in neuroblastoma- and pheochromocytoma cells.
    Bayer M; Kuçi Z; Schömig E; Gründemann D; Dittmann H; Handgretinger R; Bruchelt G
    Nucl Med Biol; 2009 Apr; 36(3):287-94. PubMed ID: 19324274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RET expression and neuron-like differentiation of pheochromocytoma and normal chromaffin cells.
    Powers JF; Picard KL; Tischler AS
    Horm Metab Res; 2009 Sep; 41(9):710-4. PubMed ID: 19551609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
    Fitzgerald PA; Goldsby RE; Huberty JP; Price DC; Hawkins RA; Veatch JJ; Dela Cruz F; Jahan TM; Linker CA; Damon L; Matthay KK
    Ann N Y Acad Sci; 2006 Aug; 1073():465-90. PubMed ID: 17102115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible autocrine enkephalin regulation of catecholamine release in human pheochromocytoma cells.
    Pellizzari EH; Barontini M; Figuerola Mde L; Cigorraga SB; Levin G
    Life Sci; 2008 Sep; 83(11-12):413-20. PubMed ID: 18706432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norepinephrine Transporter as a Target for Imaging and Therapy.
    Pandit-Taskar N; Modak S
    J Nucl Med; 2017 Sep; 58(Suppl 2):39S-53S. PubMed ID: 28864611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organic cation transporter 3 mediates the non-norepinephrine transporter driven uptake of meta-[
    Ohshima Y; Sasaki I; Watanabe S; Sakashita T; Higashi T; Ishioka NS
    Nucl Med Biol; 2022; 112-113():44-51. PubMed ID: 35802985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-κB inhibition significantly upregulates the norepinephrine transporter system, causes apoptosis in pheochromocytoma cell lines and prevents metastasis in an animal model.
    Pacak K; Sirova M; Giubellino A; Lencesova L; Csaderova L; Laukova M; Hudecova S; Krizanova O
    Int J Cancer; 2012 Nov; 131(10):2445-55. PubMed ID: 22407736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cotransfecting norepinephrine transporter and vesicular monoamine transporter 2 genes for increased retention of metaiodobenzylguanidine labeled with iodine 131 in malignant hepatocarcinoma cells.
    Zhao Y; Zhong X; Ou X; Cai H; Wu X; Huang R
    Front Med; 2017 Mar; 11(1):120-128. PubMed ID: 28213878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of urotensin-II on proliferation of pheochromocytoma cells and mRNA expression of urotensin-II and its receptor in pheochromocytoma tissues.
    Zeng ZP; Liu GQ; Li HZ; Fan XR; Liu DM; Tong AL; Zheng X; Liu C
    Ann N Y Acad Sci; 2006 Aug; 1073():284-9. PubMed ID: 17102097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation quality-dependent bystander effects elicited by targeted radionuclides.
    Boyd M; Sorensen A; McCluskey AG; Mairs RJ
    J Pharm Pharmacol; 2008 Aug; 60(8):951-8. PubMed ID: 18644188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of malignant pheochromocytoma with 131I MIBG: a long survival].
    Arias Martínez N; Barbado Hernández FJ; Couto Caro R; Gil Guerrero L; Coronado Poggio M; Navarro T; Gómez Cerezo J; Casal Esteban V; Vázquez Rodríguez JJ
    An Med Interna; 2003 Nov; 20(11):575-78. PubMed ID: 14624651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas.
    Havekes B; van der Klaauw AA; Weiss MM; Jansen JC; van der Mey AG; Vriends AH; Bonsing BA; Romijn JA; Corssmit EP
    Endocr Relat Cancer; 2009 Jun; 16(2):527-36. PubMed ID: 19289533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal pheochromocytoma producing vasoactive intestinal peptide and masking hypertension.
    Ozbay A; Obukhau A; Buhl L; Brøndt Hartlev L; Løgstrup Poulsen P
    Horm Res; 2008; 70(3):188-92. PubMed ID: 18663320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of metastases from malignant pheochromocytoma in patients undergoing 131I-MIBG therapy with manually fused 123I-MIBG SPECT and CT images.
    Kizu H; Takayama T; Tsushima H; Noguchi A; Nakajima K; Onoguchi M; Kinuya S
    J Nucl Med Technol; 2008 Dec; 36(4):186-8. PubMed ID: 19008288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Courses of malignant pheochromocytoma: implications for therapy.
    Sisson JC; Shulkin BL; Esfandiari NH
    Ann N Y Acad Sci; 2006 Aug; 1073():505-11. PubMed ID: 17102118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinediones inhibit the growth of PC12 cells both in vitro and in vivo.
    Kim SW; Choi OK; Chang MS; Shin CS; Park KS; Kim SY
    Biochem Biophys Res Commun; 2008 Jun; 371(2):197-202. PubMed ID: 18423377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the norepinephrine transporter by alpha-synuclein-mediated interactions with microtubules.
    Jeannotte AM; Sidhu A
    Eur J Neurosci; 2007 Sep; 26(6):1509-20. PubMed ID: 17714497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges.
    Manger WM
    Ann N Y Acad Sci; 2006 Aug; 1073():1-20. PubMed ID: 17102067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.